» Articles » PMID: 21800839

Identification and Biological Activities of New Taccalonolide Microtubule Stabilizers

Overview
Journal J Med Chem
Specialty Chemistry
Date 2011 Aug 2
PMID 21800839
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The taccalonolides are a unique class of microtubule stabilizers that do not bind directly to tubulin. Three new taccalonolides, Z, AA, and AB, along with two known compounds, taccalonolides R and T, were isolated from Tacca chantrieri and Tacca integrifolia. Taccalonolide structures were determined by 1D and 2D NMR methods. The biological activities of the new taccalonolides, as well as taccalonolides A, B, E, N, R, and T, were evaluated. All nine taccalonolides display microtubule stabilizing activity, but profound differences in antiproliferative potencies were noted, with IC(50) values ranging from the low nanomolar range for taccalonolide AA (32 nM) to the low micromolar range for taccalonolide R (13 μM). These studies demonstrate that diverse taccalonolides possess microtubule stabilizing properties and that significant structure-activity relationships exist. In vivo antitumor evaluations of taccalonolides A, E, and N show that each of these molecules has in vivo antitumor activity.

Citing Articles

Taccalonolides: Structure, semi-synthesis, and biological activity.

Li Y, Du Y, Gao F, Xu J, Zheng L, Liu G Front Pharmacol. 2022; 13:968061.

PMID: 36034793 PMC: 9407980. DOI: 10.3389/fphar.2022.968061.


Taccalonolides: A Novel Class of Microtubule-Stabilizing Anticancer Agents.

Chen X, Winstead A, Yu H, Peng J Cancers (Basel). 2021; 13(4).

PMID: 33671665 PMC: 7926778. DOI: 10.3390/cancers13040920.


Taccalonolide Microtubule Stabilizers.

Yee S, Du L, Risinger A Prog Chem Org Nat Prod. 2020; 112:183-206.

PMID: 33306174 PMC: 7800047. DOI: 10.1007/978-3-030-52966-6_3.


Development of Taccalonolide AJ-Hydroxypropyl-β-Cyclodextrin Inclusion Complexes for Treatment of Clear Cell Renal-Cell Carcinoma.

Han J, Zhang S, Niu J, Zhang C, Dai W, Wu Y Molecules. 2020; 25(23).

PMID: 33261151 PMC: 7731059. DOI: 10.3390/molecules25235586.


Beyond the Paclitaxel and Vinca Alkaloids: Next Generation of Plant-Derived Microtubule-Targeting Agents with Potential Anticancer Activity.

Zhang D, Kanakkanthara A Cancers (Basel). 2020; 12(7).

PMID: 32610496 PMC: 7407961. DOI: 10.3390/cancers12071721.


References
1.
Buey R, Barasoain I, Jackson E, Meyer A, Giannakakou P, Paterson I . Microtubule interactions with chemically diverse stabilizing agents: thermodynamics of binding to the paclitaxel site predicts cytotoxicity. Chem Biol. 2005; 12(12):1269-79. DOI: 10.1016/j.chembiol.2005.09.010. View

2.
Risinger A, Jackson E, Polin L, Helms G, LeBoeuf D, Joe P . The taccalonolides: microtubule stabilizers that circumvent clinically relevant taxane resistance mechanisms. Cancer Res. 2008; 68(21):8881-8. PMC: 2727482. DOI: 10.1158/0008-5472.CAN-08-2037. View

3.
Corbett T, Griswold Jr D, Roberts B, Peckham J, SCHABEL Jr F . Biology and therapeutic response of a mouse mammary adenocarcinoma (16/C) and its potential as a model for surgical adjuvant chemotherapy. Cancer Treat Rep. 1978; 62(10):1471-88. View

4.
Galsky M, Dritselis A, Kirkpatrick P, Oh W . Cabazitaxel. Nat Rev Drug Discov. 2010; 9(9):677-8. DOI: 10.1038/nrd3254. View

5.
Krishan A . Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J Cell Biol. 1975; 66(1):188-93. PMC: 2109516. DOI: 10.1083/jcb.66.1.188. View